ZURA today
$1.24+$0.00 (+0.00%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourDescending Triangle
1 hourStrong Bearish
15 minLeaning Bearish
5 minStrong Bullish
Daily trend turns up above $4.60
Key levels
Resistance$2.28
Resistance$1.57
Support$0.93
Latest news & SEC filings
AnalystOppenheimer Revises Its Valuation View for Zura Bio
LegalShareholder investigation announced after Zura Bio clinical trial results
AnalystOppenheimer keeps Outperform rating on Zura Bio, cuts price target to $5
AnalystGuggenheim keeps Buy rating on Zura Bio, cuts price target to $8
All ZURA news →About Zura Bio
Zura Bio is an early-stage drug developer focused on treatments for immune system and inflammation-related conditions. Its main candidate, tibulizumab, is an engineered antibody designed to block two immune signaling proteins, IL-17A and BAFF, and is in mid-stage human testing for hidradenitis suppurativa and diffuse cutaneous systemic sclerosis. Two other antibody candidates, crebankitug and torudokimab, target IL-7Rα and IL-33 respectively and were licensed from larger pharmaceutical companies. Its trials enroll patients across North America and Europe.
Based on the company's 10-K filed Mar 19, 2026.
Nasdaq · Healthcare
Zura Bio Ltd (ZURA)
What Is the Price Target for ZURA?
SEPT Low Target
$10.00
SEPT Mid Target
$10.00
SEPT High Target
$10.00
Analyst Consensus
$10.00
Is ZURA a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ZURA.
Start Free Trial →Is ZURA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$10.00
12
Moat Score
NONE
1/9
Piotroski Score
14.7
Altman Z-Score
What Is Smart Money Doing with ZURA?
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ZURA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-76.67%
FCF Growth YoY
-130.6%
Revenue Trend
UNKNOWN
Dark Pool Trades for ZURA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ZURA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:28:17 | $1.22 | 1,000 | $$1K | BUY |
| 21:02:09 | $1.24 | 3,600 | $$4K | MIDPOINT |
| 21:01:58 | $1.24 | 8,000 | $$10K | MIDPOINT |
| 21:01:50 | $1.24 | 8,000 | $$10K | MIDPOINT |
| 21:00:03 | $1.24 | 1,094 | $$1K | MIDPOINT |
5 dark pool trades shown · $$27K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ZURA
PREVIEWSEPT Investing provides real-time options flow tracking for ZURA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $1.5 | Jan 15 | 63 | $$500 | 100 | BLOCK |
| CALL | $1.5 | Jan 15 | 63 | $$500 | 100 | BLOCK |
| PUT | $1 | Mar 19 | 126 | $$3000 | 150 | BLOCK |
3 options trades shown · 67% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Zura Bio Ltd (ZURA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (6 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ZURA — frequently asked questions
What is ZURA stock price today?
Zura Bio Ltd (ZURA) is at $1.24, up 0.00% (+$0.00) at the Nov 13, 2026 close.
Why is ZURA stock moving today?
Latest ZURA news — Nov 11, 2026: Oppenheimer Revises Its Valuation View for Zura Bio · Nov 11, 2026: Shareholder investigation announced after Zura Bio clinical trial results
Why did ZURA stock move on Nov 9, 2026?
Zura Bio shares fell 2.36% to close at $1.24 after the company reported that its Phase 2 TibuSHIELD trial of tibulizumab in hidradenitis suppurativa missed its primary endpoint and other important goals. The stock traded in a wide range on heavy volume of 53.8 million shares, hitting a low of $0.93 before recovering somewhat.
What is the ZURA price target?
The average analyst price target for ZURA is $10.00, ranging from $10 to $10, based on 1 analysts. Latest: Wedbush maintains on Nov 9, 2026.
What do analysts rate ZURA?
Analyst ratings for ZURA: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did ZURA beat earnings?
ZURA last reported on Oct 27, 2026: EPS -$0.20 vs -$0.22 expected — a beat of 9.1%.
Does ZURA pay a dividend?
ZURA does not currently pay a dividend.
What are ZURA support and resistance levels?
Support: $0.93. Resistance: $1.57, $2.28, $3.27.
What are insiders doing with ZURA?
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
What is the latest news on ZURA?
Nov 11, 2026: Oppenheimer Revises Its Valuation View for Zura Bio · Nov 11, 2026: Shareholder investigation announced after Zura Bio clinical trial results · Nov 10, 2026: Oppenheimer keeps Outperform rating on Zura Bio, cuts price target to $5